An early report of a screening program for colorectal cancer in Guangzhou, China - PubMed (original) (raw)
doi: 10.21037/atm.2019.09.75.
Binyi Xiao 1, Jianhong Peng 1, Huan Tian 2, Fulong Wang 1, Lingheng Kong 1, Shiyong Lin 1, Jibin Li 1, Qiying Su 2, Kunwu Luo 2, Meixian Ye 1, Qingjian Ou 1, Wenhua Fan 1, Cong Li 1, Junzhong Lin 1, Rongxin Zhang 1, Wenhao Zhou 1, Liren Li 1, Gong Chen 1, Zhenhai Lu 1, Xiaojun Wu 1, Peirong Ding 1, Meichun Zheng 1, Xia Yang 1, Zhizhong Pan 1, Desen Wan 1
Affiliations
- PMID: 32047765
- PMCID: PMC7011592
- DOI: 10.21037/atm.2019.09.75
An early report of a screening program for colorectal cancer in Guangzhou, China
Yujing Fang et al. Ann Transl Med. 2019 Nov.
Abstract
Background: We launched a screening program for colorectal cancer (CRC) in Yuexiu District, Guangzhou, China, in 2014. Here we aimed to report the early results of the program and evaluate the benefits of a screening questionnaire.
Methods: Residents aged between 50 and 74 were eligible for the screening. A questionnaire and two consecutive fecal immunological tests (FITs) were used as primary screening methods. Subjects who were positive for any of the two tests were referred for further examination with colonoscopy. Neoplasms were removed either colonoscopically or by colectomy. Atypical adenoma and CRC were defined as advanced neoplasms.
Results: A total of 6,971 residents in Dadong Street, Yuexiu District were screened with a questionnaire, and among them, 5,343 underwent at least one FIT. Four thousand and two hundred eleven (60.4%) were female, and 2,760 (39.6%) were male, with a median age of 62.0 years. Questionnaire and FITs identified 1,219 candidates for further examination with colonoscopy, among whom only 647 (53.1%) comply. As of this writing, 623 colonoscopy results were obtained, among which 270 (43.3%) had positive findings. The adenoma detection rate (ADR) was 43.3% (270/623). The ADR was 43.3% (270/623). Of the 270 patients, 10 (3.07%) had CRC, 81 (30.0%) had advanced adenoma, 178 had low-grade adenoma or other benign polyps, one had carcinoid. Except for three advanced CRC, all neoplasms detected were benign or in an early stage.
Conclusions: Our screening program help identified patients with colonic neoplasms at an early stage, precluding them from developing into the malignant disease. The addition of the questionnaire significantly increased the sensitivity of primary screening, while also decreasing the specificity. Long-term results should evaluate the social and economic benefits of this program.
Keywords: Polyps; colorectal cancer (CRC); early screening; fecal immunological test (FITs).
2019 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment in
- Combining old and new strategies for colorectal cancer screening.
Danese E, Montagnana M, Lippi G. Danese E, et al. Ann Transl Med. 2020 Feb;8(4):67. doi: 10.21037/atm.2019.11.135. Ann Transl Med. 2020. PMID: 32175360 Free PMC article. No abstract available. - Usefulness of the mass screening program for colorectal cancer in China: further long-term validation is needed to confirm its value.
Kwon WA, Seo HK. Kwon WA, et al. Ann Transl Med. 2020 Apr;8(7):427. doi: 10.21037/atm.2020.03.33. Ann Transl Med. 2020. PMID: 32395471 Free PMC article. No abstract available.
Similar articles
- [Status quo of colorectal cancer screening in Guangzhou community].
Zhao Y, Pan Z. Zhao Y, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Nov 25;20(11):1246-1250. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 29178094 Chinese. - Screening for Colorectal Cancer: An Updated Systematic Review [Internet].
Whitlock EP, Lin J, Liles E, Beil T, Fu R, O'Connor E, Thompson RN, Cardenas T. Whitlock EP, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct. Report No.: 08-05-05124-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct. Report No.: 08-05-05124-EF-1. PMID: 20722162 Free Books & Documents. Review. - Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat. Medical Advisory Secretariat. Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article. - Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy.
Liao Y, Li S, Chen C, He X, Lin F, Wang J, Yang Z, Lan P. Liao Y, et al. Gastroenterol Rep (Oxf). 2018 May;6(2):132-136. doi: 10.1093/gastro/gox030. Epub 2017 Sep 5. Gastroenterol Rep (Oxf). 2018. PMID: 29780602 Free PMC article. - Screening for Colorectal Cancer: An Evidence Update for the U.S. Preventive Services Task Force [Internet].
Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Lin JS, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-1. PMID: 34097369 Free Books & Documents. Review.
Cited by
- Time trends of major cancers incidence and mortality in Guangzhou, China 2004-2015: A Joinpoint and Age-Period-Cohort Analysis.
Luo A, Dong H, Lin X, Liao Y, Liang B, Chen L, Lin G, Hao Y. Luo A, et al. Cancer Med. 2021 Apr;10(8):2865-2876. doi: 10.1002/cam4.3744. Epub 2021 Mar 16. Cancer Med. 2021. PMID: 33724715 Free PMC article. - Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
Li JB, Ke KJ, Zhang WL, Wang LY, Wu YP, Weng F, Tian H, Qiu ZY, Li Y, Lin SY, Ye MX, Ou QJ, Gong CH, Lu ZH, Pan ZZ, Wan DS, Peng JH, Fang YJ. Li JB, et al. Cancer Med. 2022 Nov;11(22):4321-4331. doi: 10.1002/cam4.4730. Epub 2022 Apr 20. Cancer Med. 2022. PMID: 35441812 Free PMC article. - ZIP7 (SLC39A7) expression in colorectal cancer and its correlation with clinical prognosis.
Luo Y, Shen Y, Ju Z, Zhang Z. Luo Y, et al. Transl Cancer Res. 2020 Oct;9(10):6471-6478. doi: 10.21037/tcr-20-2640. Transl Cancer Res. 2020. PMID: 35117255 Free PMC article. - Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.
Li JB, Qiu ZY, Deng YX, Li Y, Lin ZC, Wu YP, Weng F, Tian H, Ou QJ, Gong CH, Pan ZZ, Wan DS, Peng JH, Fang YJ. Li JB, et al. Discov Oncol. 2022 Jan 8;13(1):4. doi: 10.1007/s12672-022-00463-8. Discov Oncol. 2022. PMID: 35201502 Free PMC article. - Usefulness of the mass screening program for colorectal cancer in China: further long-term validation is needed to confirm its value.
Kwon WA, Seo HK. Kwon WA, et al. Ann Transl Med. 2020 Apr;8(7):427. doi: 10.21037/atm.2020.03.33. Ann Transl Med. 2020. PMID: 32395471 Free PMC article. No abstract available.
References
- Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2016. Available online: https://seer.cancer.gov/csr/1975_2016/
LinkOut - more resources
Full Text Sources
Research Materials